Article thumbnail

Meta-analysis of archived DNA microarrays identifies genes regulated by hypoxia and involved in a metastatic phenotype in cancer cells

By Michael Pierre, Benoît DeHertogh, Anthoula Gaigneaux, Bertrand DeMeulder, Fabrice Berger, Eric Bareke, Carine Michiels and Eric Depiereux
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2001). AD: A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics
  2. (2001). Affymetrix: Affymetrix Microarray Suite User Guide version 5.0. Santa Clara: Affymetrix Manual;
  3. (2007). AffyProbeMiner: a web resource for computing or retrieving accurately redefined Affymetrix probe sets. Bioinformatics
  4. (2007). Akira S: Antiviral signaling through pattern recognition receptors.
  5. (2008). al.: PAI-1 and functional blockade of SNAI1 in breast cancer cell migration. Breast Cancer Res
  6. (2003). ArrayExpress: a public database of gene expression data at EBI.
  7. (2004). Axelson H: Induction of ID2 expression by hypoxia-inducible factor-1: a role in dedifferentiation of hypoxic neuroblastoma cells.
  8. (2004). Bioconductor: open software development for computational biology and bioinformatics. Genome Biol
  9. (2004). Brakenhoff RH: Dissecting the metastatic cascade. Nat Rev Cancer
  10. (2007). CH: Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev
  11. (2008). Contribution of p53, p63, and p73 to the developmental diseases and cancer. Neoplasma
  12. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing.
  13. (2004). Creation of the whole human genome microarray. Expert Rev Proteomics
  14. (2003). Database for Annotation, Visualization, and Integrated Discovery. Genome Biol
  15. (2008). Decreased ID2 promotes metastatic potentials of Pierre et al.
  16. (2008). Del Giglio A: Management of advanced prostate cancer. Rev Assoc Med Bras
  17. (2008). Depiereux E: The "Window t test": a simple and powerful approach to detect differentially expressed genes in microarray datasets.
  18. (2001). Distinct roles of Jun: Fos and Jun: ATF dimers in oncogenesis. Oncogene
  19. (2009). DS: Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer.
  20. (2004). Early divergence of Fc epsilon receptor I signals for receptor upregulation and internalization from degranulation, cytokine production, and survival.
  21. (2001). EF: AP-1 in mouse development and tumorigenesis. Oncogene
  22. (2003). EF: AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer
  23. (2000). EM: Microarray expression profiling identifies genes with altered expression in HDLdeficient mice. Genome Res
  24. Entrez Global Query Cross-Database Search System
  25. (2005). Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res
  26. (1997). Exploring the metabolic and genetic control of gene expression on a genomic scale. Science
  27. Expression Omnibus []
  28. (2004). F: A model-based background adjustment for oligonucleotide expression arrays.
  29. (2007). F: p53 family proteins in thyroid cancer. Endocr Relat Cancer
  30. (2005). GA: Improved statistical tests for differential gene expression by shrinking variance components estimates. Biostatistics
  31. (2009). GEMS (Gene Expression MetaSignatures), a Web resource for querying meta-analysis of expression microarray datasets: 17beta-estradiol in MCF-7 cells. Cancer Res
  32. (2007). Giaccia AJ: Hypoxia, gene expression, and metastasis. Cancer Metastasis Rev
  33. (2004). HL: Pathogenic Escherichia coli. Nat Rev Microbiol
  34. (2007). Huang CL: Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer. Lung Cancer
  35. (2004). Hynes NE: ErbB receptors: directing key signaling networks throughout life. Annu Rev Pharmacol Toxicol
  36. (2007). Hypoxia-inducible factors: central regulators of the tumor phenotype. Curr Opin Genet Dev
  37. (2007). Jr: Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit Rev Oncol Hematol
  38. (1999). KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res
  39. (1991). Light-directed, spatially addressable parallel chemical synthesis. Science
  40. (2004). Linear models and empirical bayes methods for assessing differential expression in microarray experiments.
  41. (2003). Local-pooled-error test for identifying differentially expressed genes with a small number of replicated microarrays. Bioinformatics
  42. (2001). M: AP-1 in cell proliferation and survival. Oncogene
  43. (2008). Mechanisms of metastasis.
  44. (2003). Nebreda AR: Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions.
  45. (2002). Nishida E: Docking interactions in the mitogen-activated protein kinase cascades. Pharmacol Ther
  46. (2006). Obermayer K: A new summarization method for Affymetrix probe level data. Bioinformatics
  47. (2004). Oosterom AT, De Bruijn EA: Vascular endothelial growth factor and angiogenesis. Pharmacol Rev
  48. (2008). Primary brain tumors in adults. Am Fam Physician
  49. (1995). Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science
  50. (1996). R: a language for data analysis and graphics.
  51. (2009). Regularized gene selection in cancer microarray metaanalysis.
  52. (2006). RP: Hypoxia and metastasis in breast cancer. Breast Dis
  53. (2004). S: Alternative mapping of probes to genes for Affymetrix chips.
  54. (2005). Schlaepfer DD: Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol
  55. (2001). Significance analysis of microarrays applied to the ionizing radiation response.
  56. (2001). Sliwkowski MX: Untangling the ErbB signalling network. Nat Rev Mol Cell Biol
  57. (2003). Speed TP: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics
  58. (2007). Strimmer K: Accurate ranking of differentially expressed genes by a distribution-free shrinkage approach. Stat Appl Genet Mol Biol
  59. (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc
  60. (2003). The cytoskeleton, cellular motility and the reductionist agenda. Nature
  61. (2000). The mitogenactivated protein kinase extracellular signal-regulated kinase 1/2 pathway is involved in formyl-methionyl-leucyl-phenylalanineinduced p47phox phosphorylation in human neutrophils.
  62. (1908). The Probable Error of a Mean. Biometrika
  63. (2004). The role of hypoxia-induced factors in tumor progression. Oncologist
  64. (2000). Thiery JP: Focal adhesions: structure and dynamics. Biol Cell
  65. (2003). TP: A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics
  66. (2003). Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer
  67. (2008). Updated options for liver-limited metastatic colorectal cancer. Clin Colorectal Cancer
  68. (1999). Vascular endothelial growth factor (VEGF) and its receptors. Faseb J
  69. (2002). Within the fold: assessing differential expression measures and reproducibility in microarray assays. Genome Biol
  70. Wong WH: Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data.
  71. (2001). Wong WH: Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection.
  72. (2008). Yulug IG: A resampling-based meta-analysis for detection of differential gene expression in breast cancer.
  73. (2009). Zheng W: Genetic polymorphisms in the MMP-7 gene and breast cancer survival.